Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Celebi, Nevin
111  Ergebnisse:
Personensuche X
?
1

Cyclodextrin-based nanogel of flurbiprofen for dermal appli..:

Oktay, Ayse Nur ; Celebi, Nevin ; Ilbasmis-Tamer, Sibel.
Journal of Drug Delivery Science and Technology.  79 (2023)  - p. 104012 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Formulation Strategies of Nanosuspensions for Various Admin..:

Pınar, Sıla Gülbağ ; Oktay, Ayşe Nur ; Karaküçük, Alptuğ Eren.
Pharmaceutics.  15 (2023)  5 - p. 1520 , 2023
Link: https://doi.org/10.3390/..
 
?
3

A new nanosuspension prepared with wet milling method for o..:

Pınar, Sıla Gülbağ ; Canpınar, Hande ; Tan, Çağman.
European Journal of Pharmaceutical Sciences.  171 (2022)  - p. 106123 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Bas..:

Oktay, Ayse Nur ; Ilbasmis-Tamer, Sibel ; Uludag, Orhan.
Pharmaceutical Research.  38 (2021)  6 - p. 991-1009 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Evaluation of the hypoglycemic effect of exendin-4's new or..:

Celik-Tekeli, Merve ; Celebi, Nevin ; Tekeli, M. Yasin.
European Journal of Pharmaceutical Sciences.  158 (2021)  - p. 105644 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Editorial, Special Issue BBBB:

Çelebi, Nevin ; Şahin, Selma
European Journal of Pharmaceutical Sciences.  159 (2021)  - p. 105751 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Oral self-nanoemulsifying formulation of GLP-1 agonist pept..:

Tekeli, Merve Celik ; Aktas, Yesim ; Celebi, Nevin
Amino Acids.  53 (2021)  1 - p. 73-88 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Screening of stabilizing agents to optimize flurbiprofen na..:

Oktay, Ayse Nur ; Ilbasmis-Tamer, Sibel ; Karakucuk, Alptug.
Journal of Drug Delivery Science and Technology.  57 (2020)  - p. 101690 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Preparation and in vitro / in vivo evaluation of flurbiprof..:

Oktay, Ayse Nur ; Ilbasmis-Tamer, Sibel ; Han, Sevtap..
European Journal of Pharmaceutical Sciences.  155 (2020)  - p. 105548 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Investigation of Formulation and Process Parameters of Wet ..:

Karakucuk, Alptug ; Celebi, Nevin
Pharmaceutical Research.  37 (2020)  6 - p. , 2020
Link: https://doi.org/10.1007/..
 
?
11

Development of Nanocrystal Ziprasidone Orally Disintegratin..:

Tashan, Emine ; Karakucuk, Alptug ; Celebi, Nevin
AAPS PharmSciTech.  21 (2020)  3 - p. , 2020
Link: https://doi.org/10.1208/..
 
?
12

Correction to: Development of Nanocrystal Ziprasidone Orall..:

Tashan, Emine ; Karakucuk, Alptug ; Celebi, Nevin
AAPS PharmSciTech.  21 (2020)  5 - p. , 2020
Link: https://doi.org/10.1208/..
 
?
13

Evaluation of improved oral bioavailability of ritonavir na..:

Karakucuk, Alptug ; Teksin, Zeynep S. ; Eroglu, Hakan.
European Journal of Pharmaceutical Sciences.  131 (2019)  - p. 153-158 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Optimization and in vitro evaluation of ziprasidone nanosus..:

Tashan, Emine ; Karakucuk, Alptug ; Celebi, Nevin
Journal of Drug Delivery Science and Technology.  52 (2019)  - p. 37-45 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Dermal flurbiprofen nanosuspensions: Optimization with desi..:

Oktay, Ayse N. ; Karakucuk, Alptug ; Ilbasmis-Tamer, Sibel.
European Journal of Pharmaceutical Sciences.  122 (2018)  - p. 254-263 , 2018
Link: https://doi.org/10.1016/..
 
1-15